Exploring FNDC4 as a biomarker for prognosis and immunotherapy response in lung adenocarcinoma
Shengshan Xu, Zhuming Lu
Topics & Concepts
MedicineImmunotherapyBiomarkerAdenocarcinomaLung cancerOncologyLungInternal medicineCancerChemistryBiochemistryCancer-related molecular mechanisms researchCancer, Hypoxia, and MetabolismRNA modifications and cancer